What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Masatomo Mori mainly focuses on Internal medicine, Endocrinology, Immunology, Receptor and Molecular biology.
His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
Masatomo Mori works mostly in the field of Gastroenterology, limiting it down to topics relating to Reflux and, in certain cases, Hepatology, as a part of the same area of interest.
His Endocrinology study which covers Nucleobindin 2 that intersects with Nucleus.
He has researched Receptor in several fields, including Thyrotropin receptor, Transfection and Cell growth.
His studies deal with areas such as Gene, Gene knockdown, Adenoma, KRAS and Signal transduction as well as Molecular biology.
His most cited work include:
- Identification of nesfatin-1 as a satiety molecule in the hypothalamus (675 citations)
- Estrogen increases in vivo leptin production in rats and human subjects (424 citations)
- Development and evaluation of FSSG: frequency scale for the symptoms of GERD (320 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Endocrinology, Gastroenterology, Pathology and Surgery.
His study in Diabetes mellitus extends to Internal medicine with its themes.
His studies link Messenger RNA with Endocrinology.
His Gastroenterology study incorporates themes from Hepatocellular carcinoma, Reflux and Chemotherapy.
The study incorporates disciplines such as Cancer and Lung in addition to Pathology.
Masatomo Mori studies Leptin, namely Leptin receptor.
He most often published in these fields:
- Internal medicine (60.35%)
- Endocrinology (39.65%)
- Gastroenterology (15.95%)
What were the highlights of his more recent work (between 2010-2020)?
- Internal medicine (60.35%)
- Endocrinology (39.65%)
- Gastroenterology (15.95%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Endocrinology, Gastroenterology, Cancer research and Surgery are his primary areas of study.
The Internal medicine study combines topics in areas such as Diabetes mellitus and Oncology.
He combines subjects such as Nucleus, Receptor and Gene expression with his study of Endocrinology.
He works mostly in the field of Receptor, limiting it down to topics relating to Cell biology and, in certain cases, Biochemistry.
Masatomo Mori usually deals with Gastroenterology and limits it to topics linked to Ribavirin and Viral load.
His Cancer research research includes themes of Cell growth, Molecular biology, KRAS, Fibrosis and Transforming growth factor.
Between 2010 and 2020, his most popular works were:
- Diagnostic Criteria, Clinical Features, and Incidence of Thyroid Storm Based on Nationwide Surveys (179 citations)
- Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy (127 citations)
- Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. (127 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Masatomo Mori focuses on Internal medicine, Endocrinology, Cancer research, Hypothalamus and Molecular biology.
Internal medicine is often connected to Gastroenterology in his work.
His research in the fields of Energy homeostasis, Triglyceride, Insulin and Kidney overlaps with other disciplines such as Context.
His Cancer research research incorporates themes from Pancreatic tumor, Cell growth, Hepatic stellate cell, KRAS and Adenocarcinoma.
His Hypothalamus study combines topics in areas such as Satiety Response, Ultradian rhythm, Leptin and White adipose tissue.
Masatomo Mori interconnects Gene knockdown, CREB, Cyclic AMP Response Element-Binding Protein, Intracellular and Kinase in the investigation of issues within Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
